Phosphorylated mTOR Expression Profiles in Human Normal and Carcinoma Tissues

Figure 3

Immunoexpression of p-mTOR in carcinoma tissues. (a) Pancreatic adenocarcinoma shows stronger p-mTOR staining in the invasive front of the tumor (100x). The insert (right lower) shows higher magnification (400x). (b) In lung adenocarcinoma, p-mTOR staining is intensified at the tumor-normal interface (200x). (c) In papillary urothelial carcinoma, p-mTOR staining is stronger in the superficial layer of the tumor (200x). (d) In micropapillary variant of urothelial carcinoma, tumor cells show strong cytoplasmic and membranous p-mTOR staining (400x).

(a)

(b)

(c)

(d)